19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Activating α7 nicotinic acetylcholine receptor inhibits NLRP3 inflammasome through regulation of β-arrestin-1

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="cns12758-sec-0001"> <!-- named anchor --> </a> <h5 class="section-title" id="d1138986e306">Aims</h5> <p id="d1138986e308">To evaluate whether activating α7 nicotinic acetylcholine receptor (α7n <span style="fixed-case">AC</span>hR) could inhibit the <span style="fixed-case">NOD</span>‐like receptor family, pyrin domain containing 3 ( <span style="fixed-case">NLRP</span>3) inflammasome through regulation of β‐arrestin‐1 in monocyte/macrophage system, thus contributing to the control of neuroinflammation. </p> </div><div class="section"> <a class="named-anchor" id="cns12758-sec-0002"> <!-- named anchor --> </a> <h5 class="section-title" id="d1138986e320">Methods</h5> <p id="d1138986e322">The protein levels of <span style="fixed-case">NLRP</span>3, caspase‐1 (Casp‐1) p20 and proCasp‐1, interleukin‐1β ( <span style="fixed-case">IL</span>‐1β) p17 and pro <span style="fixed-case">IL</span>‐1β, <span style="fixed-case">IL</span>‐18 and pro <span style="fixed-case">IL</span>‐18 were measured using Western blotting. The <span style="fixed-case">mRNA</span> levels of Casp‐1 and <span style="fixed-case">IL</span>‐1β were detected by real‐time <span style="fixed-case">PCR</span> ( <span style="fixed-case">RT</span>‐ <span style="fixed-case">PCR</span>). The colocalization and interaction of <span style="fixed-case">NLRP</span>3 protein and β‐arrestin‐1 were measured by immunofluorescence staining and immunoprecipitation. </p> </div><div class="section"> <a class="named-anchor" id="cns12758-sec-0003"> <!-- named anchor --> </a> <h5 class="section-title" id="d1138986e359">Results</h5> <p id="d1138986e361">The expression of β‐arrestin‐1 was significantly increased and colocalized with <span style="fixed-case">CD</span>45‐positive cells in spinal cord of experimental auto‐immune encephalomyelitis ( <span style="fixed-case">EAE</span>) mice when compared with the sham mice, which was attenuated by pretreatment with <span style="fixed-case">PNU</span>282987, a specific α7n <span style="fixed-case">AC</span>hR agonist. <span style="fixed-case">PNU</span>282987 also significantly inhibited the activation of <span style="fixed-case">NLRP</span>3 inflammasome and thus decreased the production of <span style="fixed-case">IL</span>‐1β and <span style="fixed-case">IL</span>‐18 both in lipopolysaccharide ( <span style="fixed-case">LPS</span>)/ <span style="fixed-case">ATP</span>‐stimulated <span style="fixed-case">BV</span>2 microglia in vitro and spinal cord from <span style="fixed-case">EAE</span> mice in vivo <i>,</i> while inverse effects were observed in α7n <span style="fixed-case">AC</span>hR knockout mice. Furthermore, overexpression of β‐arrestin‐1 attenuated the inhibitory effect of <span style="fixed-case">PNU</span>282987 on <span style="fixed-case">NLRP</span>3 inflammasome activation in <span style="fixed-case">LPS</span>/ <span style="fixed-case">ATP</span>‐stimulated <span style="fixed-case">BV</span>2 microglia. <span style="fixed-case">PNU</span>282987 inhibited the interaction between β‐arrestin‐1 and <span style="fixed-case">NLRP</span>3 protein in vitro. </p> </div><div class="section"> <a class="named-anchor" id="cns12758-sec-0004"> <!-- named anchor --> </a> <h5 class="section-title" id="d1138986e430">Conclusions</h5> <p id="d1138986e432">The present study demonstrates that activating α7n <span style="fixed-case">AC</span>hR can lead to <span style="fixed-case">NLRP</span>3 inflammasome inhibition via regulation of β‐arrestin‐1 in monocyte/microglia system. </p> </div>

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          NLRP3 inflammasome and its inhibitors: a review

          Inflammasomes are newly recognized, vital players in innate immunity. The best characterized is the NLRP3 inflammasome, so-called because the NLRP3 protein in the complex belongs to the family of nucleotide-binding and oligomerization domain-like receptors (NLRs) and is also known as “pyrin domain-containing protein 3”. The NLRP3 inflammasome is associated with onset and progression of various diseases, including metabolic disorders, multiple sclerosis, inflammatory bowel disease, cryopyrin-associated periodic fever syndrome, as well as other auto-immune and auto-inflammatory diseases. Several NLRP3 inflammasome inhibitors have been described, some of which show promise in the clinic. The present review will describe the structure and mechanisms of activation of the NLRP3 inflammasome, its association with various auto-immune and auto-inflammatory diseases, and the state of research into NLRP3 inflammasome inhibitors.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses.

            The alpha7 nicotinic acetylcholine receptor (nAChR) was recently described as an anti-inflammatory target in both macrophages and T cells. Its expression by immune cells may explain the epidemiological data claiming a negative link between cigarette smoking and several inflammatory diseases. In this study, we determined the immunological effects of alpha7 nAChR activation by nicotine. Our results indicate that the alpha7 nAChR is expressed on the surface of CD4(+) T cells and that this expression is up-regulated upon immune activation. Nicotine reduced T cell proliferation in response to an encephalitogenic Ag, as well as the production of Th1 (TNF-alpha and IFN-gamma) and Th17 cytokines (IL-17, IL-17F, IL-21, and IL-22). IL-4 production was increased in the same setting. Attenuation of the Th1 and Th17 lineages was accompanied by reduced T-bet (50%) and increased GATA-3 (350%) expression. Overall, nicotine induced a shift to the Th2 lineage. However, alpha7(-/-)-derived T cells were unaffected by nicotine. Furthermore, nicotine reduced NF-kappaB-mediated transcription as measured by IL-2 and IkappaB transcription. In vivo, administration of nicotine (2 mg/kg s.c.) suppressed the severity of CD4(+) T cell-mediated disease experimental autoimmune encephalomyelitis. alpha7(-/-) mice were refractory to nicotine treatment, although disease severity in those animals was reduced, due to impairment in Ag presentation. Accordingly, CD4(+) and CD11b(+) cells infiltration into the CNS, demyelination, and axonal loss were reduced. Our data implicate a role for the alpha7 nAChR in immune modulation and suggest that alpha7 nAChR agonists may be effective in the treatment of inflammatory disorders.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              α7 nicotinic acetylcholine receptor signaling inhibits inflammasome activation by preventing mitochondrial DNA release.

              The mammalian immune system and the nervous system coevolved under the influence of cellular and environmental stress. Cellular stress is associated with changes in immunity and activation of the NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome, a key component of innate immunity. Here we show that α7 nicotinic acetylcholine receptor (α7 nAchR)-signaling inhibits inflammasome activation and prevents release of mitochondrial DNA, an NLRP3 ligand. Cholinergic receptor agonists or vagus nerve stimulation significantly inhibits inflammasome activation, whereas genetic deletion of α7 nAchR significantly enhances inflammasome activation. Acetylcholine accumulates in macrophage cytoplasm after adenosine triphosphate (ATP) stimulation in an α7 nAchR-independent manner. Acetylcholine significantly attenuated calcium or hydrogen oxide-induced mitochondrial damage and mitochondrial DNA release. Together, these findings reveal a novel neurotransmitter-mediated signaling pathway: acetylcholine translocates into the cytoplasm of immune cells during inflammation and inhibits NLRP3 inflammasome activation by preventing mitochondrial DNA release.
                Bookmark

                Author and article information

                Journal
                CNS Neuroscience & Therapeutics
                CNS Neurosci Ther
                Wiley
                17555930
                November 2017
                November 2017
                September 21 2017
                : 23
                : 11
                : 875-884
                Affiliations
                [1 ]Department of Pharmacology; Second Military Medical University; Shanghai China
                [2 ]Naval Convalescent Zone of Hangzhou Sanatorium; Nanjing Military Command; Hangzhou China
                [3 ]Cardiovascular Research Center; Temple University School of Medicine; Philadelphia PA USA
                [4 ]State Key Laboratory Breeding Base for Zhejiang Sustainable Plant Pest and Disease Control; Zhejiang Province Key Laboratory for Food Safety; Zhejiang Academy of Agricultural Sciences; Institute of Quality and Standard for Agro-products; Hangzhou China
                Article
                10.1111/cns.12758
                6492746
                28941191
                f625e2e7-7caf-46d1-b9e1-efcd6ba7cb7b
                © 2017

                http://doi.wiley.com/10.1002/tdm_license_1.1

                http://onlinelibrary.wiley.com/termsAndConditions#vor

                History

                Comments

                Comment on this article